Webb12 maj 2024 · At the time of writing, our data shows that Prothena Corporation plc has a market capitalization of US$1.0b, and reported total annual CEO compensation of US$3.4m for the year to December 2024. Webb18 jan. 2024 · As the Insider of Prothena Co. plc, Mr. Malecek earned a total compensation package of $1,177,755.00 in 2024. Mr. Malecek earned a salary of $410,000.00, options awards of $589,505.00, non-equity compensation of $164,000.00, and other compensation of $14,250.00. Learn More on Michael J. Malecek's salary.
In Memoriam Prothena
WebbOverview. Company Description: Key Principal: YVONNE TCHRAKIAN See more contacts. Industry: Business Support Services , Administrative and Support Services , … Webb12 apr. 2024 · Their PRTA share price forecasts range from $55.00 to $120.00. On average, they predict the company's stock price to reach $82.50 in the next year. This suggests a possible upside of 68.8% from the stock's current price. View analysts price targets for PRTA or view top-rated stocks among Wall Street analysts. hss total ankle replacement
Prothena CEO and key executive team Craft.co
Webb12 juli 2024 · Prothena Corporation plc Media & Investors Jennifer Zibuda, Director, Investor Relations & Communications +1 650 837 8535, [email protected]. … WebbProthena's key executives include Gene G. Kinney and 16 others. Gene G. Kinney President and Chief Executive Officer, Director Michael J. Malecek Chief Legal Officer and Company Secretary Carol D. Karp Chief Regulatory Officer David Anderson Chief Regulatory Officer Radhika Tripuraneni Chief Development Officer Brandon Smith Chief Business Officer WebbProthena Biosciences Neotope Biosciences Ltd Revenue $201.6 M Employees 82 Primary Industries Pharmaceuticals Manufacturing Research & Development Business Services Funding History Prothena raised a total of $122.1 M in funding over 1 rounds, and is a public traded company. CEO Gene Kinney Stock Symbol NASDAQ: PRTA hochoka healing center